• No results found

Translational pharmacology of dopamine receptor agonists and antagonists : prolactin and oxytocin as biomarkers Stevens, J.

N/A
N/A
Protected

Academic year: 2021

Share "Translational pharmacology of dopamine receptor agonists and antagonists : prolactin and oxytocin as biomarkers Stevens, J."

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Translational pharmacology of dopamine receptor agonists and antagonists : prolactin and oxytocin as biomarkers

Stevens, J.

Citation

Stevens, J. (2011, September 22). Translational pharmacology of dopamine receptor agonists and antagonists : prolactin and oxytocin as biomarkers.

Retrieved from https://hdl.handle.net/1887/17851

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/17851

Note: To cite this publication please use the final published version (if

applicable).

(2)
(3)

Jasper Stevens was born on February 3rd, 1979 in Geldrop, The Netherlands.

After graduating from High School in 1998 at the Dr. Nassau College in Assen, he started the study Biology at the University of Groningen.

After two 6-month-internships at the depart-ment of Neuroendocrinology at the University

of Groningen and the department of Pharma- cology at Organon N.V. in Oss, he obtained his master’s degree in Biology in November 2004, with the examination components “Behavioral and Cognitive Sciences” and “M variant Science, Policy and Business”.

In 2005 he started a PhD project at Leiden University under the supervision of Prof. dr. M. Danhof and dr. E. De Lange, that resulted in this thesis.

In 2010 he started as Disease and Therapeutic Response Modeling Program Fellow at the Indiana Clinical and Translational Sciences Institute in Indianapolis, IN, USA.

Referenties

GERELATEERDE DOCUMENTEN

Principal areas of focus for group 3.3 are the mechanisms of disease related to acute lung injury (e.g. acute respiratory distress syndrome), fibrotic reactions, injury created

effect relationships and biological system responses. Challenging the model with other dopaminergic compounds provides an even stronger basis for the estimation of the biological

4 Online solid phase extraction with liquid chromatography-tandem mass spectrometry to analyze remoxipride in small plasma-, brain homogenate-, and brain microdialysate samples 59.

Using the newly developed animal model and analytical methods, we can obtain serial datapoints in plasma and close to, if not at, the target site following intravenous and

effect relationships and biological system responses. Challenging the model with other dopaminergic compounds provides an even stronger basis for the estimation of the biological

Methods. Male Wistar rats received one intranasal cannula, an intracerebral microdialysis probe, and two blood cannulas for drug administration and serial blood sampling

For experiments in rats, we here propose analytical methods for the detec- tion of low concentrations remoxipride in small sample volumes of plasma, brain homogenate,

The absorption rate constant from the nose to the brain was low when compared to the absorption rate constant for systemic uptake, explaining the relatively slow decrease in plasma-